Company Analysis

Immutep Limited (IMMP)

Nasdaq: IMMP · Pharmaceutical Preparations · Sydney,, AU · filing with the SEC since 2012
Grade5.7
◀ Past 5.7● Present 5.5▶ Future 5.9
2 est.

Income statement, as filed

In Australian dollars (AUD), as filed; per-share figures in Australian dollars; share counts. The fiscal year ends in June.

The Form 20-F filed Oct 23, 2026 for the period ended Jun 30, 2026 is not in EDGAR's company facts yet; its figures print once EDGAR carries them.

Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period endingJun 30, 2025Jun 30, 2024Jun 30, 2023Jun 30, 2022Jun 30, 2021Jun 30, 2020Jun 30, 2019Jun 30, 2018Jun 30, 2017Jun 30, 2016
Report filedOct 24, 2025Oct 22, 2024Oct 24, 2023Oct 31, 2022Oct 25, 2021Sep 25, 2020Sep 23, 2019Oct 19, 2018Oct 19, 2017Jun 28, 2017
Revenue10,331,3737,838,6255,200,1286,758,0733,968,13316,499,9687,489,4047,353,3074,221,5342,028,921
Research and development49,778,91631,472,06328,793,38525,337,53812,020,71415,572,040r13,770,953r9,989,8307,525,7447,059,528
General and administrative8,644,5038,852,6158,679,8407,210,1236,282,1056,338,652r6,369,661r7,242,0614,346,9526,982,629
Finance costs37,07830,59420,40192,4309,82510,4570··8,199
Interest income5,287,2093,882,757938,999224,520105,327199,541397,281177,186104,368264,043
Income before income taxes-61,434,165-42,716,625-39,896,348-32,210,792-29,902,591-13,468,195-18,343,984-12,744,344-10,104,593-63,196,201
Income tax expense00034333701,676-737,387-1,181,017
Net income-61,434,165-42,716,625-39,896,348-32,210,826-29,902,624-13,468,232-18,343,984-12,746,020-9,367,206-62,015,184
Net income to shareholders-61,434,165-42,716,625-39,896,348-32,210,826-29,902,624-13,468,232-18,343,984-12,746,020-9,367,206-62,015,184
Earnings per share, basic-0.0422-0.0356-0.0447-0.0379-0.0503r-0.0326r-5.29r-4.63r-0.40r-2.78
Earnings per share, diluted-0.0422-0.0356-0.0447-0.0379-0.0503r-0.0326r-5.29r-4.63r-0.40r-2.78
Weighted average shares, basic1,455,818,4421,201,061,930892,399,810848,968,068594,927,440412,855,961r346,805,822r275,103,115r2,370,387,786r2,228,477,348
Weighted average shares, diluted1,455,818,4421,201,061,930892,399,810848,968,068594,927,440412,855,961r346,805,822r275,103,115r2,370,387,786r2,228,477,348
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldifrs-full:Revenue
Research and development spent on inventing what it sells nextifrs-full:ResearchAndDevelopmentExpense
General and administrative the cost of running the company itselfifrs-full:GeneralAndAdministrativeExpense
Finance costs what its borrowing costifrs-full:FinanceCosts
Interest income what its cash and investments earnedifrs-full:RevenueFromInterest
Income before income taxes profit before taxifrs-full:ProfitLossBeforeTax
Income tax expense tax charged on the period's profitifrs-full:IncomeTaxExpenseContinuingOperations
Net income the whole group's profit, minority holders' share includedifrs-full:ProfitLoss
Net income to shareholders the profit or loss that belongs to the company's shareholdersifrs-full:ProfitLossAttributableToOwnersOfParent
Earnings per share, basic net income per share outstandingifrs-full:BasicEarningsLossPerShare
Earnings per share, diluted net income per share, counting every share that could be issuedifrs-full:DilutedEarningsLossPerShare
Weighted average shares, basic the average count of shares outstandingifrs-full:WeightedAverageShares
Weighted average shares, diluted the average count with every share that could be issuedifrs-full:AdjustedWeightedAverageShares
SI Assistanton IMMP · research, not advice